CCAAT/enhancer-binding protein is epigenetically silenced by Histone Deacetylation in endometriosis and promotes the pathogenesis of endometriosis

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 9, 2013, Pages

  Kawano, Yukie ^a   Nasu, Kaei ^a   Hijiya, Naoki ^a   Tsukamoto, Yoshiyuki ^a   Amada, Kohei ^a   Abe, Wakana ^a   Kai, Kentaro ^a   Moriyama, Masatsugu ^a   Narahara, Hisashi ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AIFM1 PROTEIN; APOPTOSIS INDUCING FACTOR; CASPASE 10; CASPASE 8; CCAAT ENHANCER BINDING PROTEIN ALPHA; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HISTONE; HISTONE DEACETYLASE 1; HISTONE H3; HISTONE H4; INTERLEUKIN 8; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PER2 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN BAX; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VALPROIC ACID;

ABCB1 GENE; ADULT; APOPTOSIS; ARTICLE; CCAAT ENHANCER BINDING PROTEIN ALPHA GENE; CEBPA GENE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEACETYLATION; DOWN REGULATION; ENDOMETRIOSIS; ENDOMETRIUM CELL; EPIGENETICS; FEMALE; GENE; GENE IDENTIFICATION; GENE SILENCING; HISTONE ACETYLATION; HISTONE DEACETYLATION; HUMAN; HUMAN CELL; IL8 GENE; MICROARRAY ANALYSIS; MT1G GENE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PPP2R2B GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; STROMA CELL; UPREGULATION;

ACETYLATION; ADULT; APOPTOSIS; APOPTOSIS INDUCING FACTOR; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; ENDOMETRIOSIS; EPIGENESIS, GENETIC; FEMALE; GENE SILENCING; HISTONES; HUMANS; OVARIAN DISEASES; PERIOD CIRCADIAN PROTEINS; PPAR GAMMA; STROMAL CELLS; VALPROIC ACID;

EID: 84883693745     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1608     Document Type: Article

References (40)

1. Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364:1789-1799.
2. Nishida M, Nasu K, Ueda T, Fukuda J, Takai N, Miyakawa I. Endometriotic cells are resistant to interferon-induced cell growth inhibition and apoptosis: a possible mechanism involved in the pathogenesis of endometriosis. Mol Hum Reprod. 2005;11:29-34.
3. Braun DP, Ding J, Shaheen F, Willey JC, Rana N, Dmowski WP. Quantitative expression of apoptosis-regulating genes in endometrium from women with and without endometriosis. Fertil Steril. 2007;87:263-268.
4. Pellegrini C, Gori I, Achtari C, et al. The expression of estrogen receptors as well as GREB1, c-MYC, and cyclin D1, estrogen-regulated genes implicated in proliferation, is increased in peritoneal endometriosis. Fertil Steril. 2012;98:1200-1208.
5. Watanabe A, Taniguchi F, Izawa M, Suou K, Uegaki T, Takai E, Terakawa N, Harada T. The role of survivin in the resistance of endometriotic stromal cells to drug-induced apoptosis. Hum Reprod. 2009;24:3172-3179.
6. Gogusev J, Bouquet de Joliniere J, Telvi L, et al. Detection of DNA copy number changes in human endometriosis by comparative genomic hybridization. Hum Genet. 1999;105:444-451.
7. Goumenou AG, Arvanitis DA, Matalliotakis IM, Koumantakis EE, Spandidos DA. Microsatellite DNA assays reveal an allelic imbalance in p16(Ink4), GALT, p53, and APOA2 loci in patients with endometriosis. Fertil Steril. 2001;75:160-165.
8. Kawano Y, Nasu K, Li H, et al. Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target. Hum Reprod. 2011;26:2486-2498.
9. Abe W, Nasu K, Nakada C, Kawano Y, Moriyama M, Narahara H. miR-196b targets c-myc and Bcl-2 expression, inhibits proliferation and induces apoptosis in endometriotic stromal cells. Hum Reprod. 2013;28:750-761.
10. Pazin MJ, Kadonaga JT. What's up and down with histone deacetylation and transcription? Cell. 1997;89:325-328.
11. Matsuura K, Nakada C, Mashio M, et al. Downregulation of SAV1 plays a role in pathogenesis of high-grade clear cell renal cell carcinoma. BMC Cancer. 2011;11:523.
12. Izawa M, Harada T, Deura I, Taniguchi F, Iwabe T, Terakawa N. Drug-induced apoptosis was markedly attenuated in endometriotic stromal cells. Hum Reprod. 2006;21:600-604.
13. Takai N, Kawamata N, Walsh CS, et al. 2005 Discovery of epigenetically masked tumor suppressor genes in endometrial cancer.Mol Cancer Res. 2005;3:261-269.
14. Yoon K, Smart RC. C/EBP is a DNA damage-inducible p53-regulated mediator of the G1 checkpoint in keratinocytes. Mol Cell Biol. 2004;24:10650-10660.
15. Ramji DP, Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J. 2002;365:561-575.
16. Yang S, Fang Z, Suzuki T, et al. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBP in endometriosis is associated with overexpression of aromatase. J Clin Endocrinol Metab. 2002;87:2336-2345.
17. Oh HS, Smart RC. Expression of CCAAT/enhancer binding proteins (C/EBP) is associated with squamous differentiation in epidermis and isolated primary keratinocytes and is altered in skin neoplasms. J Invest Dermatol. 1998;110:939-945.
18. Radomska HS, Huettner CS, Zhang P, Cheng T, Scadden DT, Tenen DG. CCAAT/enhancer binding protein is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol. 1998;18:4301-4314.
19. Pabst T, Mueller BU, Zhang P, et al. Dominant-negative mutations of C/EBPA, encoding CCAAT/enhancer binding protein- (C/EBP ), in acute myeloid leukemia. Nat Genet. 2001;27:263-270.
20. Gery S, Tanosaki S, Bose S, Bose N, Vadgama J, Koeffler HP. Downregulation and growth inhibitory role of C/EBP in breast cancer. Clin Cancer Res. 2005;11:3184-3190.
21. Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein activity in lung cancer. J Natl Cancer Inst. 2006; 98:396-406.
22. Bennett KL, Hackanson B, Smith LT, et al. Tumor suppressor activity of CCAAT/enhancer binding protein is epigenetically downregulated in head and neck squamous cell carcinoma. Cancer Res. 2007;67:4657-4664.
23. Timchenko NA, Wilde M, Nakanishi M, Smith JR, Darlington GJ. CCAAT/enhancer-binding protein (C/EBP) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev. 1996;10:804-815.
24. Timchenko NA, Wilde M, Iakova P, Albrecht JH, Darlington GJ. E2F/p107 and E2F/p130 complexes are regulated by C/EBP in 3T3-L1 adipocytes. Nucleic Acids Res. 1999;27:3621-3630.
25. Wang H, Iakova P, Wilde M, et al. C/EBP arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol Cell. 2001;8:817-828.
26. Wang H, Goode T, Iakova P, Albrecht JH, Timchenko NA. C/EBP triggers proteasome-dependent degradation of cdk4 during growth arrest. EMBO J. 2002;21:930-941.
27. Johansen LM, Iwama A, Lodie TA, et al. c-Myc is a critical target for C/EBP in granulopoiesis. Mol Cell Biol. 2001;21:3789-3806.
28. Wang X, Huang G, Mei S, Qian J, Ji J, Zhang J. Over-expression of C/EBP- induces apoptosis in cultured rat hepatic stellate cells depending on p53 and peroxisome proliferator-activated receptor-. Biochem Biophys Res Commun. 2009;380:286-291.
29. Shen SM, Yu Y, Wu ZX, Zheng Y, Chen GQ, Wang LS. Apoptosisinducing factor is a target gene of C/EBP and participates in adipocyte differentiation. FEBS Lett. 2011;585:2307-2312.
30. Thoennissen NH, Thoennissen GB, Abbassi S, et al. Transcription factor CCAAT/enhancer-binding protein and critical circadian clock downstream target genePER2are highly deregulated in diffuse large B-cell lymphoma. Leuk Lymphoma. 2012;53:1577-1585.
31. Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 1999;397:441-446.
32. Rosen ED, Hsu CH, Wang X, et al. C/EBP induces adipogenesis through PPAR: a unified pathway. Genes Dev. 2002;16:22-26.
33. Wu YV, Okada T, DeCarolis P, et al. Restoration of C/EBP in dedifferentiated liposarcoma induces G2/M cell cycle arrest and apoptosis. Genes Chromosomes Cancer. 2012;51:313-327.
34. Inoue I, Hayashi K, Yagasaki F, et al. Apoptosis of endothelial cells may be mediated by genes of peroxisome proliferator-activated receptor 1 (PPAR 1) and PPAR genes. J Atheroscler Thromb. 2003;10:99-108.
35. Harper JW, Elledge SJ. Cdk inhibitors in development and cancer. Curr Opin Genet Dev. 1996;6:56-64.
36. Ko LJ, Prives C. p53: Puzzle and paradigm. Genes Dev. 1996;10: 1054-1072.
37. Nakayama J, Rice JC, Strahl BD, Allis CD, Grewal SI. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science. 2001;292:110-113.
38. Timchenko N, Wilson DR, Taylor LR, et al. Autoregulation of the human C/EBP gene by stimulation of upstream stimulatory factor binding. Mol Cell Biol. 1995;15:1192-1202.
39. Kumagai T, Akagi T, Desmond JC, et al. Epigenetic regulation and molecular characterization of C/EBP in pancreatic cancer cells. Int J Cancer. 2009;124:827-833.
40. Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility. Fertil Steril. 2004;81:1441-1446.